HCV peptide antigens and methods for the determination of HCV

US6592871B1 · kind B1 · utility

Assignee

• Roche Diagnostics GMBH · DE

Inventors

• Christoph Seidel · Weilheim, DE
• Gertraud Ehrlich-Weinreich · Deggendorf, DE
• Hubert Bayer · Weilheim, DE
• Ursula-Henrike Wienhues · Krailling, DE
• Gunther Jung · Tübingen, DE
• Hans-Georg Ihlenfeldt · Iffeldorf, DE

Key dates

• Filing date: Oct 13, 2000
• Grant date: Jul 15, 2003
• Expiry date: Oct 13, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2770/24222
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel HCV peptide antigens are described representing partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the production of antibodies against HCV and as vaccines for the production of vaccines against HCV.